Michal Zikan Selected Research

Lymphocele

3/2019	Ultrasound characteristics of a symptomatic and asymptomatic lymphocele after pelvic and/or paraaortic lymphadenectomy.
1/2018	A collagen-fibrin patch for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: A randomized clinical trial.
5/2015	A prospective study examining the incidence of asymptomatic and symptomatic lymphoceles following lymphadenectomy in patients with gynecological cancer.
8/2014	A collagen-fibrin patch (Tachosil®) for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: a randomized clinical trial.
3/2014	Lymphocele: prevalence and management in gynecological malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michal Zikan Research Topics

Disease

21	Neoplasms (Cancer) 06/2022 - 03/2005
8	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 11/2010
7	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2007
5	Lymphocele 03/2019 - 03/2014
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017 - 05/2009
2	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 11/2013
1	Toxoplasmosis 01/2022
1	Ascites 06/2020
1	Inflammation (Inflammations) 01/2019
1	Circulating Neoplastic Cells 12/2017
1	Endometriosis 12/2017
1	Sarcoma (Soft Tissue Sarcoma) 03/2017
1	Smooth Muscle Tumor 03/2017
1	Adenosarcoma 03/2017
1	Leiomyosarcoma 03/2017
1	Endometrial Stromal Sarcoma 03/2017
1	Pain (Aches) 05/2015
1	Hydronephrosis 05/2015
1	Lymphedema (Milroy Disease) 05/2015
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2015
1	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2011
1	Carcinoma (Carcinomatosis) 01/2011
1	Neoplasm Metastasis (Metastasis) 01/2010
1	Aneuploidy (Aneuploid) 07/2007

Drug/Important Bio-Agent (IBA)

7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2009
3	Biomarkers (Surrogate Marker)IBA 12/2017 - 11/2013
2	Hormones (Hormone)IBA 06/2022 - 01/2022
2	A-Form DNA (A-DNA)IBA 01/2022 - 01/2014
2	CollagenIBA 01/2018 - 08/2014
2	FibrinIBA 01/2018 - 08/2014
2	Cell-Free Nucleic AcidsIBA 12/2017 - 12/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Progesterone FDA LinkGeneric 01/2022
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2019
1	Suppositories (Vaginal Suppositories)IBA 01/2019
1	Gemcitabine FDA Link 12/2017
1	hydrogen sulfite (bisulfite)IBA 12/2017
1	Diphosphonates (Bisphosphonates)IBA 12/2017
1	Docetaxel (Taxotere)FDA Link 12/2017
1	Circulating Tumor DNAIBA 12/2017
1	Ribosomal Proteins (Ribosomal Protein)IBA 03/2017
1	Transcription Factors (Transcription Factor)IBA 11/2013
1	EnzymesIBA 02/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2011
1	Combined Oral ContraceptivesIBA 08/2011
1	Oral ContraceptivesIBA 08/2011
1	5' Untranslated Regions (5' UTR)IBA 12/2007
1	Aurora Kinase AIBA 07/2007
1	Coloring Agents (Dyes)IBA 02/2007
1	Nonsense Codon (Nonsense Mutation)IBA 03/2005

Therapy/Procedure

7	Lymph Node Excision (Lymph Node Dissection) 03/2019 - 01/2011
2	Laparotomy 06/2020 - 03/2014
2	Neoadjuvant Therapy 12/2017 - 01/2016
2	Radiotherapy 01/2017 - 03/2014
2	Trachelectomy 01/2017 - 01/2016
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2022
1	Punctures 06/2020
1	Tubal Sterilization (Tubal Ligation) 01/2019
1	Adjuvant Chemotherapy 12/2017
1	Drug Therapy (Chemotherapy) 12/2017
1	Hysterectomy 05/2015
1	Chemoprevention 08/2011
1	Salpingo-oophorectomy 08/2011
1	Ligation 11/2010
1	Injections 02/2007